it is a question of who is going to subsidize global pharma R&D? same drug costs $10k in US is sold for $5k in EU and $10 in India. The biggest question is: W

it is a question of who is going to subsidize global pharma R&D? same drug costs $10k in US is sold for $5k in EU and $10 in India. The biggest question is: Why should US consumer subsidize pharma R&D so that pharma can sell it globally and hoard profits in Switzerland? note: all pharma companies are incorporated in a way to pay de-minimus tax in US/EU/Asia via transfer pricing schemes and hoard all extra profits in Switzerland because of Swiss laws taxing licensing IP only at 15% example: 1. Pharma, Inc sells drug for $10,000 in US 2. it licenses IP from Swiss entity and swiss entity charges it $9999 royalty 3. Pharma, Inc pays US tax on $1 of profit at 35% 4. Swiss entity records $9999 profit and pays 15% tax so US consumer is screwed in the end. US consumer think twice: do you want to pay $10,000 for a drug + $20,000 in insurance premium+copay when you can travel to India/Egypt/Turkey/Germany and get the same treatment for the same brand name drug for 1/10 (or 1/1000 of cost). We need to talk about geographical arbitrage of healthcare costs more